En

Search

Health
Professionals
Careers
Investors
Investors
Partners
Partners
News
News

About Us

Products

Research

Contact Us Health Professionals

Responsibility
Careers

Health & Wellness

Investors

Partners

News

Therapeutic
Science
R&D
Clinical
Partnering
Trials
& Technology
Areas
Immunology
CV
Neuroscience
Vaccines
Oncology
Rare
&Disease
Metabolic
Home
Research&& Therapeutic Areas Vaccines
Inflammation
Diseases
Pain

Vaccines

Pfizer has a rich history in vaccine research and development. Over the years, weve played a pivotal role in
nearly eliminating the world of deadly diseases like smallpox and polio, and designing diverse vaccine
delivery systems and technologies that have resulted in vaccines to prevent bacterial infections, like
pneumococcal disease.
Our vaccine R&D program includes an ongoing focus on the prevention of pneumococcal disease, including
in adults. We are also advancing vaccines for additional deadly adolescent and adult infections including
Meningococcal B, Staphylococcus aureus and Clostridium difficile. We are leveraging leading technology in
vaccine design and conjugation in an effort to provide preventative solutions to these complex, difficult-totreat bacterial pathogens.
Pfizer is also exploring the power of novel therapeutic vaccines to provide long-lasting treatment benefits
for chronic conditions and diseases such as smoking addiction and allergic asthma. Vaccines can generate
high-levels of antibodies in the body that could prove beneficial for managing these difficult conditions.

Like

Pipeline in Focus
We are currently conducting clinical trials
with new vaccines designed to prevent
deadly infections such as Meningococcal
B, hospital-acquired Staphylococcus
aureus infection and Clostridium difficile
colitis. We are also advancing therapeutic
vaccines for smoking cessation and
allergic asthma.

Work with Us
If youre interested in collaborating with us on vaccine development, visit our Vaccines Partnering page to
learn more about the work were pursuing.

Emilio Emini, Ph.D., Senior Vice President of

Vaccine Research & Development at Pfizer,

discusses the impact of vaccines and evolution of

vaccine research.

Pfizers Vaccine R&D

Pfizer is tackling deadly adult and adolescent
infectious diseases, and evaluating therapeutic
vaccines for chronic disease and conditions.
Learn more PDF

Career-seekers

Health Professionals

Change Country

Terms of Use

Investors

Partners

Contact Us

Privacy Policy

News & Media

Business to Business

Sitemap

Copyright 20022014 Pfizer Inc. All rights reserved. This information - including product information - is intended only for residents of the United States. The products discussed herein
may have different labeling in different countries.